期刊
NEURON
卷 101, 期 4, 页码 560-583出版社
CELL PRESS
DOI: 10.1016/j.neuron.2019.01.049
关键词
-
资金
- European Union's Horizon 2020 research and innovation program under the ERA-NET Cofund action [643578, 779257]
- BMBF [01GM1607]
- DFG [SCHO754/5-2]
- Else Kroner Fresenius Stiftung [2015_EKMS.018]
Autosomal-recessive cerebellar ataxias (ARCAs) comprise a heterogeneous group of rare degenerative and metabolic genetic diseases that share the hallmark of progressive damage of the cerebellum and its associated tracts. This Review focuses on recent translational research in ARCAs and illustrates the steps from genetic characterization to preclinical and clinical trials. The emerging common pathways underlying ARCAs include three main clusters: mitochondrial dysfunction, impaired DNA repair, and complex lipid homeostasis. Novel ARCA treatments might target common hubs in pathogenesis by modulation of gene expression, stem cell transplantation, viral gene transfer, or interventions in faulty pathways. All these translational steps are addressed in current ARCA research, leading to the expectation that novel treatments for ARCAs will be reached in the next decade.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据